Jan 4, 2017
Analyst Activity – Feltl & Co. Initiates Coverage On Kindred Biosciences (NASDAQ:KIN) With a Strong-Buy
Analyst Activity – Feltl & Co. Initiates Coverage On Kindred Biosciences (NASDAQ:KIN) With a Strong-Buy
Analyst Ratings For Kindred Biosciences (NASDAQ:KIN) Today, Feltl & Co. initiated coverage on Kindred Biosciences (NASDAQ:KIN) with a Strong-Buy. There are 1 hold rating, 1 buy rating, 1 strong buy rating on the stock. The current consensus rating on Kindred Biosciences (NASDAQ:KIN) is Buy (Score: 3.00) with a consensus target price of $7.25 per share, a potential 40.78% upside. Some recent…
View On WordPress